Michael Lue-Yat is currently the Associate Director of Clinical Trial Management at Cara Therapeutics. Prior to this role, Michael has held various positions in clinical trial management at companies such as Purdue Pharma L.P., Aerotek, PRA Health Sciences, Execupharm, Roche, and Memorial Sloan-Kettering Cancer Center. Michael graduated from Stony Brook University with a Bachelor of Arts degree in Psychology in 2004.
March 1, 2024 - present
March, 2022
May, 2018